JAMES FISCO: Open Payments
NPI 1245233766 · SPRINGBORO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,745 in 173 payments from 26 companies in 2025. Trend: 2023 $2,940 · 2024 $2,677 · 2025 $2,745
Food & beverage: $2,745
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $494 |
| ABBVIE INC. | 38 | $397 |
| Bayer Healthcare Pharmaceuticals Inc. | 39 | $392 |
| Novo Nordisk Inc | 13 | $191 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $152 |
| Lilly USA, LLC | 9 | $131 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Amgen Inc. | 5 | $82 |
| Dexcom, Inc. | 1 | $82 |
Products named: Kerendia, BREZTRI, QULIPTA, UBRELVY, JARDIANCE, AIRSUPRA, MOUNJARO, Ozempic.
Industry payments across OH — which companies pay providers there.
